Clinical trials are studies of new or experimental treatments in patients, and they are a critical component in expanding treatment options for people with all types of cancer.

Since all new therapies must be evaluated through clinical trials, the greater the number of people who participate, the faster emerging anti-cancer therapies can be brought to market. These trials also provide patients with access to therapies that are still in development, but might offer specific advantages for their specific type of cancer. 

As part of the US Oncology Research network, oncologists are able to participate in a clinical trial research program that has played a pivotal role in 35 of the last 41 cancer drugs approved by the Food and Drug Administration (FDA). Our community-based research program specializes in Phase I – IV cancer clinical trials for many different types of cancer. For a complete list of trials currently being held at US Oncology network practices, click here.